# 18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques

> **NCT02607748** · PHASE4 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 41 (actual)

## Conditions studied

- Coronary Artery Disease
- Atherosclerotic Plaque

## Interventions

- **OTHER:** 18F-NaF PET and coronary CTA imaging

## Key facts

- **NCT ID:** NCT02607748
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-13
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607748, "18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02607748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*